
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
Ekaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 59-59
Open Access | Times Cited: 83
Ekaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 59-59
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 387
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 387
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber, Leo D. Wang
EBioMedicine (2022) Vol. 77, pp. 103941-103941
Open Access | Times Cited: 221
Diana Gumber, Leo D. Wang
EBioMedicine (2022) Vol. 77, pp. 103941-103941
Open Access | Times Cited: 221
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
Dongze Wu, Yingzhao Jin, Yuhan Xing, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102193-102193
Open Access | Times Cited: 53
Dongze Wu, Yingzhao Jin, Yuhan Xing, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102193-102193
Open Access | Times Cited: 53
Exosomes: A potential tool for immunotherapy of ovarian cancer
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 51
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 51
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
Alex G. Hamilton, Kelsey L. Swingle, Ryann A. Joseph, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Open Access | Times Cited: 43
Alex G. Hamilton, Kelsey L. Swingle, Ryann A. Joseph, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Open Access | Times Cited: 43
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Adoptive Immunotherapy beyond CAR T-Cells
Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 743-743
Open Access | Times Cited: 78
Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 743-743
Open Access | Times Cited: 78
Infectious complications of CAR T-cell therapy: a clinical update
Adam G. Stewart, Andrea S. Henden
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 70
Adam G. Stewart, Andrea S. Henden
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 70
Recent advances in biomaterial-boosted adoptive cell therapy
Yonger Xue, Junyi Che, Xuemei Ji, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 5, pp. 1766-1794
Closed Access | Times Cited: 48
Yonger Xue, Junyi Che, Xuemei Ji, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 5, pp. 1766-1794
Closed Access | Times Cited: 48
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, et al.
Blood Advances (2022) Vol. 7, Iss. 5, pp. 768-777
Open Access | Times Cited: 47
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, et al.
Blood Advances (2022) Vol. 7, Iss. 5, pp. 768-777
Open Access | Times Cited: 47
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 14
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 14
Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
Xia Li, Mi Shao, Xiangjun Zeng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 47
Xia Li, Mi Shao, Xiangjun Zeng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 47
CAR-T State of the Art and Future Challenges, A Regulatory Perspective
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11803-11803
Open Access | Times Cited: 19
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11803-11803
Open Access | Times Cited: 19
CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects
Mahmood S. Choudhery, Taqdees Arif, Ruhma Mahmood, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3202-3202
Open Access | Times Cited: 7
Mahmood S. Choudhery, Taqdees Arif, Ruhma Mahmood, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3202-3202
Open Access | Times Cited: 7
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Vitaly Chasov, Mikhail M. Zaripov, Regina Mirgayazova, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Vitaly Chasov, Mikhail M. Zaripov, Regina Mirgayazova, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
Giovanni Palladini, Paolo Milani, Fabio Malavasi, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 545-545
Open Access | Times Cited: 32
Giovanni Palladini, Paolo Milani, Fabio Malavasi, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 545-545
Open Access | Times Cited: 32
Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
Carlos M. Moreno, Christopher Haynie, Abigail Cheever, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 25
Carlos M. Moreno, Christopher Haynie, Abigail Cheever, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 25
Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis
Gülçin Telli Dizman, José María Aguado, Mario Fernández‐Ruiz
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 11, pp. 1455-1476
Open Access | Times Cited: 25
Gülçin Telli Dizman, José María Aguado, Mario Fernández‐Ruiz
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 11, pp. 1455-1476
Open Access | Times Cited: 25
Cell-based therapies for rheumatoid arthritis: opportunities and challenges
Yujing Li, Zhu Chen
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 23
Yujing Li, Zhu Chen
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 23
Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies
Zhaozhao Chen, Yu Hu, Heng Mei
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 15
Zhaozhao Chen, Yu Hu, Heng Mei
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 15
MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens
Anais N. Bauer, Niska Majumdar, Frank Williams, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1334-1334
Open Access | Times Cited: 13
Anais N. Bauer, Niska Majumdar, Frank Williams, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1334-1334
Open Access | Times Cited: 13
A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases
Salim Hussein Hassan, Mohammad Y. Alshahrani, Raed Obaid Saleh, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 5
Salim Hussein Hassan, Mohammad Y. Alshahrani, Raed Obaid Saleh, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 5
T-regulatory cells for the treatment of autoimmune diseases
Marina Fisher, С. В. Сенников
Frontiers in Immunology (2025) Vol. 16
Open Access
Marina Fisher, С. В. Сенников
Frontiers in Immunology (2025) Vol. 16
Open Access
Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products
Dongyang Li, Xingguo Lan, Linyi Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dongyang Li, Xingguo Lan, Linyi Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A wearable device for continuous monitoring of circulating cells at single-cell resolution
Kyuho Jang, Shivam N. Kajale, Baju Joy, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Kyuho Jang, Shivam N. Kajale, Baju Joy, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access